SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(van Mourik M)
 

Sökning: WFRF:(van Mourik M) > PRAISE :

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00013445naa a2200841 4500
001oai:DiVA.org:uu-452202
003SwePub
008211027s2021 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:147150744
009oai:DiVA.org:umu-185757
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4522022 URI
0247 a https://doi.org/10.1016/j.cmi.2021.02.0282 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1471507442 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1857572 URI
040 a (SwePub)uud (SwePub)kid (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a van Mourik, Maaike S. M.u Univ Med Ctr Utrecht, Dept Med Microbiol & Infect Control, HP G04-614,Hei Delberglaan 100, NL-3584 CX Utrecht, Netherlands.,Department of Medical Microbiology and Infection Control, University Medical Center Utrecht, Netherlands,Infection Prevention and Control Department, Imperial College Healthcare NHS Trust, UK, United Kingdom4 aut
2451 0a PRAISE :b providing a roadmap for automated infection surveillance in Europe
264 1b Elsevier,c 2021
338 a electronic2 rdacarrier
520 a Introduction: Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance of HAI is a key component of successful infection prevention programmes. Conventional surveillance - manual chart review - is resource intensive and limited by concerns regarding interrater reliability. This has led to the development and use of automated surveillance (AS). Many AS systems are the product of in-house development efforts and heterogeneous in their design and methods. With this roadmap, the PRAISE network aims to provide guidance on how to move AS from the research setting to large-scale implementation, and how to ensure the delivery of surveillance data that are uniform and useful for improvement of quality of care. Methods: The PRAISE network brings together 30 experts from ten European countries. This roadmap is based on the outcome of two workshops, teleconference meetings and review by an independent panel of international experts. Results: This roadmap focuses on the surveillance of HAI within networks of healthcare facilities for the purpose of comparison, prevention and quality improvement initiatives. The roadmap does the following: discusses the selection of surveillance targets, different organizational and methodologic approaches and their advantages, disadvantages and risks; defines key performance requirements of AS systems and suggestions for their design; provides guidance on successful implementation and maintenance; and discusses areas of future research and training requirements for the infection prevention and related disciplines. The roadmap is supported by accompanying documents regarding the governance and information technology aspects of implementing AS. Conclusions: Large-scale implementation of AS requires guidance and coordination within and across surveillance networks. Transitions to large-scale AS entail redevelopment of surveillance methods and their interpretation, intensive dialogue with stakeholders and the investment of considerable resources. This roadmap can be used to guide future steps towards implementation, including designing solutions for AS and practical guidance checklists. (C) 2021 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng
653 a Automated
653 a Bloodstream infection
653 a Data
653 a Electronic health record
653 a Healthcare-associated infection
653 a Quality
653 a Surgical site infection
653 a Surveillance
7001 a van Rooden, Stephanie M.u Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.;Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands.,Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands; Centre for Infectious Disease Epidemiology and Surveillance National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands4 aut
7001 a Abbas, Mohamedu Geneva Univ Hosp, Infect Control Programme, Geneva, Switzerland.,Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland4 aut
7001 a Aspevall, Olovu Publ Hlth Agcy Sweden, Unit Surveillance & Coordinat, Solna, Sweden.,Unit for Surveillance and Coordination, Public Health Agency of Sweden, Solna, Sweden4 aut
7001 a Astagneau, Pascalu Sorbonne Univ, AP HP, Ctr Prevent Healthcare Associated Infect, Paris, France.;Sorbonne Univ, Fac Med, Paris, France.,Centre for Prevention of Healthcare-Associated Infections, Assistance Publique - Hôpitaux de Paris & Faculty of Medicine, Sorbonne University, Paris, France4 aut
7001 a Bonten, Marc J. M.u Univ Med Ctr Utrecht, Dept Med Microbiol & Infect Control, HP G04-614,Hei Delberglaan 100, NL-3584 CX Utrecht, Netherlands.;Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.,Department of Medical Microbiology and Infection Control, University Medical Center Utrecht, Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands4 aut
7001 a Carrara, Elenau Univ Verona, Dept Diagnost & Publ Hlth, Infect Dis Sect, Verona, Italy.,Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Italy4 aut
7001 a Gomila-Grange, Ainau Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Infect Dis Unit, Barcelona, Spain.;Consorci Corporacio Sanitaria Parc Tauli, Infect Dis Unit, Barcelona, Spain.,Infectious Diseases Unit, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, Barcelona, Infectious Diseases Unit, Consorci Corporació Sanitària Parc Taulí, Barcelona, Spain4 aut
7001 a de Greeff, Sabine C.u Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands.,Centre for Infectious Disease Epidemiology and Surveillance National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands4 aut
7001 a Gubbels, Sophieu Statens Serum Inst, Data Integrat & Anal Secretariat, Copenhagen, Denmark.,Data Integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark4 aut
7001 a Harrison, Wendyu Publ Hlth Wales, Antimicrobial Resistance & Prescribing Programme, Healthcare Associated Infect, Cardiff, Wales.,Healthcare Associated Infections, Antimicrobial Resistance and Prescribing Programme (HARP), Public Health Wales, UK, United Kingdom4 aut
7001 a Humphreys, Hilaryu Beaumont Hosp, Royal Coll Surg Ireland, Dept Clin Microbiol, Dept Microbiol, Dublin, Ireland.,Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Department of Microbiology, Beaumont Hospital, Dublin, Ireland4 aut
7001 a Johansson, Anders,d 1966-u Umeå universitet,Infektionssjukdomar4 aut0 (Swepub:umu)anjo0135
7001 a Koek, Mayke B. G.u Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands.,Centre for Infectious Disease Epidemiology and Surveillance National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands4 aut
7001 a Kristensen, Brianu Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark.,Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark4 aut
7001 a Lepape, Alainu Ctr Hosp Univ Lyon Sud, Dept Intens Care, Clin Res Unit, F-69495 Pierre Benite, France.,Clinical Research Unit, Department of Intensive Care, Centre Hospitalier Universitaire Lyon Sud, Pierre-Bénite, France4 aut
7001 a Lucet, Jean-Christopheu Hop Bichat Claude Bernard, AP HP, Infect Control Unit, Paris, France.,Infection Control Unit, Hôpital Bichat-Claude Bernard Assistance Publique - Hôpitaux de Paris, Paris, France4 aut
7001 a Mookerjee, Siddharthu Imperial Coll Healthcare NHS Trust, Infect Prevent & Control Dept, London, England.4 aut
7001 a Naucler, Pontusu Karolinska Institutet,Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden4 aut
7001 a Palacios-Baena, Zaira R.u Hosp Univ Virgen Macarena, Inst Biomed Seville I BIS, Unit Infect Dis Clin Microbiol & Prevent Med, Seville, Spain.,Unit of Infectious Diseases, Clinical Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, Institute of Biomedicine of Seville (I. BIS), Sevilla, Spain4 aut
7001 a Presterl, Elisabethu Med Univ Vienna, Dept Infect Control & Hosp Epidemiol, Vienna, Austria.,Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Austria4 aut
7001 a Pujol, Miquelu Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Infect Dis Unit, Barcelona, Spain.;Consorci Corporacio Sanitaria Parc Tauli, Infect Dis Unit, Barcelona, Spain.,Infectious Diseases Unit, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, Barcelona, Infectious Diseases Unit, Consorci Corporació Sanitària Parc Taulí, Barcelona, Spain4 aut
7001 a Reilly, Jacquiu Glasgow Caledonian Univ, Inst Appl Hlth Res, Safeguarding Hlth Infect Prevent Res Grp, Glasgow, Lanark, Scotland.,Safeguarding Health Through Infection Prevention Research Group, Institute for Applied Health Research, Glasgow Caledonian University, Scotland, United Kingdom4 aut
7001 a Roberts, Christopheru Publ Hlth Wales, Antimicrobial Resistance & Prescribing Programme, Healthcare Associated Infect, Cardiff, Wales.,Healthcare Associated Infections, Antimicrobial Resistance and Prescribing Programme (HARP), Public Health Wales, UK, United Kingdom4 aut
7001 a Tacconelli, Evelinau Univ Verona, Dept Diagnost & Publ Hlth, Infect Dis Sect, Verona, Italy.;Univ Hosp Tubingen, DZIF Ctr, Infect Dis Res Clin Unit, Tubingen, Germany.,Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Italy; Infectious Diseases, Research Clinical Unit, DZIF Center, University Hospital Tübingen, Germany4 aut
7001 a Teixeira, Danielu Geneva Univ Hosp, Infect Control Programme, Geneva, Switzerland.,Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland4 aut
7001 a Tängdén, Thomasu Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ, Dept Med Sci, Uppsala, Sweden.,Department of Medical Sciences, Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)thota437
7001 a Valik, John Karlssonu Karolinska Institutet,Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden4 aut
7001 a Behnke, Michaelu Charite Univ Med Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany.;Free Univ Berlin, Berlin, Germany.;Humboldt Univ, Inst Hyg & Environm Med, Berlin, Germany.,National Reference Center for Surveillance of nosocomial Infections, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Hygiene and Environmental Medicine, Berlin, Germany4 aut
7001 a Gastmeier, Petrau Charite Univ Med Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany.;Free Univ Berlin, Berlin, Germany.;Humboldt Univ, Inst Hyg & Environm Med, Berlin, Germany.,National Reference Center for Surveillance of nosocomial Infections, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Hygiene and Environmental Medicine, Berlin, Germany4 aut
7102 a Univ Med Ctr Utrecht, Dept Med Microbiol & Infect Control, HP G04-614,Hei Delberglaan 100, NL-3584 CX Utrecht, Netherlands.b Department of Medical Microbiology and Infection Control, University Medical Center Utrecht, Netherlands4 org
7730 t Clinical Microbiology and Infectiond : Elsevierg 27, s. S3-S19q 27<S3-S19x 1198-743Xx 1469-0691
8564 u https://doi.org/10.1016/j.cmi.2021.02.028y Fulltext
8564 u https://uu.diva-portal.org/smash/get/diva2:1606485/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u http://www.clinicalmicrobiologyandinfection.com/article/S1198743X21001129/pdf
8564 u https://umu.diva-portal.org/smash/get/diva2:1577993/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-452202
8564 8u https://doi.org/10.1016/j.cmi.2021.02.028
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:147150744
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-185757

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy